Figure 1. Antibody ch14.18/CHO therapy associated clinical symptoms, laboratory parameters frequency of co-medication and pain management. All 16 patients were evaluated for ch14.18/CHO associated side effects including clinical symptoms and laboratory changes (A), the use of supportive care medication (B) and pain management including pain management related side effects (C). The data are given in percentage of patients separated for each course (course 1: white bar, course 2: gray bar, course 3: black bar). The absolute number of patients is additionally provided for each column.